BDBM50091847 4-((S)-5-[Bis-(4-benzyloxy-benzyl)-amino]-5-{12-[(R)-2-[bis-(4-benzyloxy-benzyl)-amino]-6-(4-carboxy-butyrylamino)-hexanoylamino]-dodecylcarbamoyl}-pentylcarbamoyl)-butyric acid::CHEMBL437982
SMILES OC(=O)CCCC(=O)NCCCC[C@@H](N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1)C(=O)NCCCCCCCCCCCCNC(=O)[C@H](CCCCNC(=O)CCCC(O)=O)N(Cc1ccc(OCc2ccccc2)cc1)Cc1ccc(OCc2ccccc2)cc1
InChI Key InChIKey=KZFSMGHQTJGNKN-KEHSNIBCSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50091847
TargetErythropoietin receptor(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
The R. W. Johnson Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 8.50E+4nMAssay Description:Compound was evaluated for inhibition of [125I]-EPO binding to Erythropoietin receptor (EBP)More data for this Ligand-Target Pair